The partners will adapt Eukarÿs' C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.

A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their performance.

The investment license allows Kraig Biocraft Labs to scale production significantly and begin addressing requests for materials and quote.

Researchers say study represents a resource that could also help to dissect Y-gene functions in other tissues.

BioChatter can be adapted to specific research areas to pull data from biomedical databases and literature. Further, ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...

Despite all of today’s options for optimizing the bioprocessing of fungal secondary metabolites, researchers pointed out the ...

“If you use a Google maps analogy,” explains Alex Ward, PhD, co-founder of Tolemy Bio. “Then we’re bypassing bottlenecks in ...

A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by ...

The discussion of bioprocess innovation has traditionally focused on high-throughput analytics, machine learning, and automation but less so on the systems that capture the data they generate, ...

Researchers aim to continue studying the role of the X chromosome in brain aging, and whether it can explain people’s risk of brain diseases or memory loss.